Skip to main content

Table 3 Mendelian randomisation studies using genetic risk scores (GRSs) to explore causality between uricaemia and cardiovascular outcomes; negative studies

From: Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options

Author year (ref)

Instrumental variable (GRS)

Effect on SUA variance

No. of participants

Population

Accounted for pleiotropy

Main results

Stark 2009 [73]

10 SNPs

 

CAD: 1473; controls: 1241

Germany

No

No association with CAD

Yang 2010 [66]

8 SNPs

6%

>50,000

Europe and United States

No

Association with gout but not with BP, glucose level, CKD, CAD

Pfister 2011 [67]

8 SNPs

 

T2DM: 7504;

controls: 8560

 

No association of the GRS SNPs with confounders

No association with diabetes

Hughes 2013 [68]

5 SNPs, urate transporters

2%

>70,000

ARIC and FIJS cohorts

Likely to explain the observation

Association with improved renal function

Rasheed 2014 [17]

5 SNPs, urate transporters

2%

>70,000

ARIC and FIJS cohorts

No

No causal link with triglycerides; triglycerides cause hyperuricaemia

Sedaghat 2015 [69]

30 SNPs

2 mg/dL

5791

Rotterdam cohort

No

Negative association with SBP and DBP stronger in diuretic users

Sluijs 2015 [70]

24 loci

4%

>41,500

Europeans: EOIC interact and DIAGRAM cohorts

No pleiotropy except for triglycerides level

No association with diabetes

Yan 2016 [65]

17 SNPs

14 excluded

 

T2DM: >3200

China

Cross-sectional

Exclusion of 14 pleiotropic genes or in linkage disequilibrium

Association with diabetic macro-angiopathy

Keenan 2016 [74]

28 SNPs

14 excluded

 

T2DM: 65,000; controls: 68,000

CHD: 54,500; controls: 68,275

HF: 4553; controls: 19,985

IS: 14,800; controls: 19,900

Europe

South Asia

Exclusion of 14 pleiotropic genes

Association with gout

No association with T2DM, CAD, stroke, HF

White 2016 [72]

31 SNPs

 

>166,000

>9800 CHD events

17 observational cohorts, mainly from the United Kingdom

Multivariate analysis

Egger Mendelian randomisation

Multivariate OR 1–1.22; Egger OR 0.92–1.22

  1. BP blood pressure, CAD cardiovascular disease, CHD cardiac heart disease, DBP diastolic blood pressure, GRS genetic risk score, HF heart failure, OR odds ratio, SBP systolic blood pressure, SNP single nucleotide polymorphism, SUA soluble uric acid IS ischemic stroke, T2DM type 2 diabetes mellitus